News | Mobile Devices | September 23, 2016

Smartphone Communication Streamlines Hospital Transfers for Heart Attack Patients

Linking medical teams, app helps patients get faster access to treatment during nights and weekends

smartphones, hospital tranfers, heart attack patients, JACC study, South Korea

September 23, 2016 — Smartphone communication among medical teams at different hospitals can significantly reduce the time it takes for heart attack patients to get lifesaving treatment after a hospital transfer, according to a research letter published in the Journal of the American College of Cardiology.

The study tracked the length of time patients with ST-elevated myocardial infarction (STEMI), the most severe type of heart attack, suffered a reduction in blood supply, known as ischemia, while waiting to undergo a procedure to open their blocked arteries. The researchers found patients needing a hospital transfer received this procedure on average 27 minutes faster when their medical teams used a smartphone app-based social network system (SNS) to coordinate the hospital transfer compared to teams communicating with a non-smartphone based STEMI hotline. The benefit was especially pronounced during nights and weekends, when on-call medical teams may be off site and have to travel to the hospital to perform the procedure.

“SNS activation is a simple and cost-effective method suitable for broad utilization and implementation among health care providers to reduce the total ischemic time for transferred STEMI patients,” said Jin Joo Park, M.D., assistant professor of internal medicine at Seoul National University Bundang Hospital, South Korea, and one of the study’s senior researchers. “In my opinion, SNS activation can potentially save lives without using new resources in the healthcare system.”

Read the article "How Smartphones and Apps May Change the Face of Healthcare."

Percutaneous coronary intervention (PCI), also known as angioplasty, is the preferred and most common treatment for opening blocked arteries and restoring blood flow, known as reperfusion, in STEMI patients. However, not all hospitals are equipped to perform this procedure and some can only perform it during weekdays. Previous research has shown that patients requiring a hospital transfer before receiving PCI have a longer total ischemic time and worse outcomes.

Seeking to reduce the time patients must wait to receive this lifesaving treatment, researchers connected healthcare providers at five non-PCI equipped hospitals with providers at Seoul National University Bundang Hospital, which has around-the-clock PCI capabilities, via a smartphone application known as BAND. BAND is a popular social networking app in South Korea that facilitates communication among groups.

When transferring a STEMI patient to the hospital, physicians used the app to send the interventional cardiologist basic patient information along with a picture of the patient’s electrocardiogram taken with a smartphone camera. The interventional cardiologist used this information to rapidly gather a team to perform PCI, paging on-call personnel when needed, so that in most cases the responding team assembled at the hospital before the transfer patient entered the Seoul National University Bundang Hospital Emergency Department.

The study enrolled 114 STEMI patients transferred to Seoul National University Bundang Hospital during an 18-month period. Fifty of the patients were transferred using the SNS app and the rest were transferred using a non-smartphone based STEMI hotline. SNS was associated with a 27-minute reduction, on average, in the length of time from first medical contact to receiving PCI. One key factor that likely contributed to this reduction was the time spent waiting to undergo PCI after arriving at the second hospital, which was more than 15 minutes shorter when SNS was used to facilitate a transfer for patients presenting during off-hours. The use of SNS in these cases reduced the wait time at the second hospital to that experienced by patients arriving during weekdays.

“Transferred STEMI patients rarely achieve timely reperfusion due to delays in the transfer process, especially when transferred during off-hours,” Park said, noting that there is strong evidence that STEMI patients arriving to a hospital off-hours face a higher risk of death, a trend observed worldwide. “The use of a smartphone SNS can help to achieve timely reperfusion for transferred STEMI patients with rapid, seamless communication among healthcare providers.”

The time spent in transit between the two hospitals was similar in both groups. The time spent at the first hospital before being transferred was numerically shorter in the SNS-activated group, but this difference was not statistically significant.

Ischemia deprives tissues of oxygen, causing damage to the heart. If blood flow is not restored quickly enough, STEMI can lead to death or the permanent loss of heart tissue, resulting in long-term health effects and increasing the risk of another heart attack.

The study is limited in that it is not a randomized controlled trial and does not assess whether the use of SNS to streamline the transfer process actually saves patients’ lives or improves their quality of life. Park and his team are currently planning a randomized clinical trial to provide a more rigorous evaluation of the potential impact of SNS use on these outcomes.

None of the authors had disclosures to report.

For more information: www.jacc.org

Related Content

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Overlay Init